To gain a better understanding of the mechanisms through which BET inhibitors regulate cell growth and death in prostate cancer cell lines, we analyzed basal expression of BET proteins and several oncogenes that are known drivers in prostate cancer, including ERG, MYC, and AR (Figure 2). The gene discussed is MYC; the disease is prostate cancer.